# OnCo record nct06819319 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06819319/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06819319", "NCT06819319" ;
  schema:name "SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer"@en ;
  schema:description "A phase 2 trial of SHR-A2102 and adebrelimab in triple-negative breast cancer, run by Henan Cancer Hospital, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06819319/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06819319> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "tnbc-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/tnbc-early/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/shr-a2102/>, <https://onco.cc/drugs/adebrelimab/> .